Form 8-K - Current report:
SEC Accession No. 0001193125-24-274327
Filing Date
2024-12-10
Accepted
2024-12-10 16:01:56
Documents
14
Period of Report
2024-12-10
Items
Item 8.01: Other Events

Document Format Files

Seq Description Document Type Size
1 8-K d913585d8k.htm   iXBRL 8-K 25165
  Complete submission text file 0001193125-24-274327.txt   186051

Data Files

Seq Description Document Type Size
2 XBRL TAXONOMY EXTENSION SCHEMA nams-20241210.xsd EX-101.SCH 3569
3 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE nams-20241210_def.xml EX-101.DEF 14184
4 XBRL TAXONOMY EXTENSION LABEL LINKBASE nams-20241210_lab.xml EX-101.LAB 23100
5 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE nams-20241210_pre.xml EX-101.PRE 15032
16 EXTRACTED XBRL INSTANCE DOCUMENT d913585d8k_htm.xml XML 5857
Mailing Address GOOIMEER 2-35 NARRDEN P7 1411 DC
Business Address GOOIMEER 2-35 NARRDEN P7 1411 DC 35 206 2971
NewAmsterdam Pharma Co N.V. (Filer) CIK: 0001936258 (see all company filings)

EIN.: 000000000 | State of Incorp.: P7 | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-41562 | Film No.: 241538425
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)